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Introduction
Host immunity against microbial pathogens comprises de-
fense at the portal of entry (the skin and mucosa) together 
with innate and adaptive immune responses. The innate 
immune system maintains tissue homeostasis and provides 
a first-line cellular defense against microbial infections. 
The process is regulated, in significant measure, by mono-
nuclear phagocytes (MP; dendritic cells, monocytes, tissue 
macrophages, and microglia). MPs play pivotal roles in an-
tigen capture and presentation, pathogen and tissue de-
bris clearance, cellular secretory functions. MP populations 
originate in bone marrow from promonocytes (van Furth 
et al., 1982; van Furth, 1992) and are widely distributed 
throughout the body from monocyte pools including, but 
not limited to, lymphoid tissue, liver, lung, gastrointestinal 
tract, and the nervous system. Despite their common ori-
gin, macrophages are heterogeneous populations based on 
the residing tissues (Gordon et al., 1988; Morris et al., 1991; 
Laskin et al., 2001). Whether this translates into functional 
(Gordon et al., 1988) and antigenic differences (Taylor et 
al., 2003; Guillemin and Brew, 2004) is not completely un-
derstood. MP heterogeneity may be simply a consequence 
of cell exposure to the tissue microenvironment including 
local growth factors (Naito et al., 1996). The latter would 
include, but not be limited to, macrophage and granulo-
cyte-macrophage colony-stimulating factors (M-CSF and 
GM-CSF), that affect MP differentiation, proliferation and 
activation (Kaplan et al., 1992; Cecchini et al., 1994; de Vil-
liers et al., 1994, 1998; Hamilton, 1997).
The properties of MPs are studied following cell isola-
tion and cultivation under defined laboratory conditions. 
This permits investigations of cell function and molecu-
lar profiles independent of the tissue microenvironment. 
In order to address the role that genetics and environ-
ment play in MP heterogeneity, we isolated bone marrow 
(BM) and spleen (SPL) macrophages and brain microglia 
(MG) under the same culture medium and tested whether 
the cells display unique protein signatures. A unique pro-
teomic pattern of MPs was shown by Surface Enhanced 
Laser Desorption Ionization-Time of Flight (SELDI-TOF) 
ProteinChip® profiles and substantiated high-performance 
liquid chromatography (HPLC) fractionation and liquid 
chromatography tandem mass spectrometry (LC-MS/MS) 
protein identification. The results provide specific protein 
signatures for MP supporting the concept that both the tis-
sue microenvironment and genetic composition affect cel-
lular heterogeneity.
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Abstract
Mononuclear phagocytes (MP; dendritic cells, monocytes, tissue macrophages, and microglia) maintain tissue homeostasis and provide a 
first line of defense against invading pathogens. In specific circumstances, MPs also induce inflammatory responses and as such affect dis-
ease onset and progression. Despite intensive research into MP biology, little is known of the functional and molecular properties of individ-
ual MP subtypes. Using a novel proteomics platform, unique protein patterns and protein identities were observed among populations of 
spleen and bone marrow macrophages and microglia. Cells were obtained from C57BL/6 mice and were cultivated in macrophage colony-
stimulating factor. MP subtypes were indistinguishable by morphological or antigenic criteria. Protein profiling by Surface Enhanced Laser 
Desorption Ionization-Time of Flight (SELDI-TOF) ProteinChip® assays with weak cationic exchange chips showed unique MP spectral pro-
files. Corresponding protein fractions were recovered by high performance liquid chromatography and identified by liquid chromatography 
tandem mass spectrometry. The results provide a unique means to distinguish microglia from other MP subtypes. 
Keywords: cellular proteins, proteomics, microglia, macrophages
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Materials and Methods
Cell Cultures
BM and SPL macrophages and MG were prepared from 
C57BL/6 (male, 8-12 weeks old), and neonatal mice (1-2 
days old), respectively (Charles River Laboratory, Wilm-
ington, MA). To obtain BM-macrophages, both femurs 
were removed and placed in Hanks’ balanced salt solu-
tion (HBSS) at 4°C. A 5-ml syringe with a 26-gauge nee-
dle was inserted into the BM cavity and flushed with 
HBSS until the cavity appeared white. After dissociation 
of red cells with 0.15 M NH4Cl, 10 mM KHCO3, 0.1 mM 
Na2EDTA, pH 7.2 (lysis buffer), the cell suspension was 
passed through a 40-μm filter. The BM cells were cultured 
for 7 days in complete medium (CM; Dulbecco’s modi-
fied Eagle’s medium [DMEM] supplemented with 10% fe-
tal bovine serum (FBS), 2 mM L-glutamine, 1% penicillin/
streptomycin) with 2 μg/ml M-CSF. Nonadherent cells 
were removed from flasks at 1, 4, and 7 days by succes-
sive DMEM washes.
SPL macrophages were obtained by mechanically disso-
ciating spleens in HBSS and then passing the cells through 
a wire mesh. After dissociation of red cells with lysis buf-
fer, the cell suspension was passed through a 40-μm fil-
ter. The cells were cultured for 7 days in CM containing M-
CSF. Nonadherent cells were removed from the flasks at 1, 
4, and 7 days.
MG were prepared using previously described tech-
niques (Dobrenis, 1998). Brains were removed and placed 
in HBSS at 4°C. The tissue was triturated gently by pipet-
ting through a 10-ml pipette. The cell suspension was then 
incubated in 0.1% trypsin at 37°C for 30 min. After add-
ing cold heat-inactivated FBS, the tissue was washed sev-
eral times with cold HBSS and filtered through a 40-μm 
filter. The cells were then cultured for 7 days in CM with 
M-CSF. To obtain highly purified MG, the culture flasks 
were shaken gently, and the supernatants containing float-
ing MG were transferred to a new flask. The new flasks 
were incubated for 30 min to allow the MG to adhere; loose 
cells were then removed from the flask by washing with 
DMEM. The adherent MG was cultured for an additional 
7-10 days. MP purity was confirmed by CD11b immunocy-
tochemical and by morphological examination. CD11b was 
expressed in >98% cells, regardless of tissue site. All MP 
subtypes demonstrated enlarged horseshoe-shaped nuclei, 
dense granular cytoplasm, microvillus processes, prom-
inent rough-surfaced endoplasmic reticulum, and large 
numbers of endosomes, lysosomes, mitochondria, and cy-
toplasmic vacuoles.
Preparation of Cell Lysates for Proteomic Analysis
Cells were washed three times with phosphate-buffered sa-
line (PBS), aliquoted, and stored at -80°C before use. Ly-
sates were prepared with 5 mM Tris-HCl, pH 8.0, protease 
inhibitor cocktail (Sigma, St Louis, MO), and either 2% Tri-
ton X-100 or 2% 3-[(3-cholamidopropyl) dimethylammo-
nio]-1-propanesulfonate (CHAPS). Protein was quantified 
using the BCA Protein Assay (Pierce; Rockford, IL) follow-
ing the manufacturer’s instructions.
The protein signatures of whole cell lysates was per-
formed by SELDI-TOF ProteinChip assays (Ciphergen 
Biosystems, Fremont, CA). The chip types (WCX2, SAX2, 
and H50) and the washing conditions (0.1 M ammo-
nium acetate, pH 4-10; 50 mM Tris-HCl, pH 4-10; acetoni-
trile [ACN], 0-50%) were optimized before analysis. Pro-
teinChip with weak cationic exchange chemistry (WCX2) 
was selected to profile each of the three cell lysates. The 
spot surface of each WCX2 chip was pretreated with 10 
mM HCl and was equilibrated with wash buffer (0.1 M 
ammonium acetate, pH 4.0, with 0.1% Triton X-100). An 
aliquot of cell lysate mixture (0.25 μg) was applied to each 
spot and incubated in a bioprocessor at room temperature 
for 30 min with shaking. Unbound proteins were removed 
by washing spots twice with wash buffer and then with 
HPLC grade water. After drying of the spot, 100% sinapic 
acid (SPA) was applied to each spot and air-dried. SPA 
was prepared as a saturated solution in energy absorbing 
molecule solvent containing 30% ACN, 15% isopropanol, 
0.5% trifluoroacetic acid, and 0.05% Triton X-100. The ion-
ized proteins and their molecular mass/charge (m/z) ra-
tios were detected using SELDI-TOF analysis. The SELDI-
TOF mass spectra were collected by a PBS II ProteinChip 
Biosystems and analyzed with ProteinChip software 3.2 
(both from Ciphergen Biosystems). The ProteinChip anal-
yses were performed in triplicate, three separate times 
and on three independent macrophage cultures; the data 
set from each MP comprised a minimum of 30 spectra. 
The ProteinChip Reader was externally calibrated for 
each analysis using the four standard proteins: bovine in-
sulin (5,733.6 Da), cytochrome C (12,230.9 Da), superox-
ide dismutase (SOD) (15,591.4 Da), and β-lactoglobulin 
(18,363.3 Da). Peaks were automatically detected using 
the Biomarker Wizard of ProteinChip software 3.2. The 
following parameters for peak detection were used: first-
pass signal/noise (S/N) ratio = 5, second-pass S/N ratio 
= 2, and mass tolerance = 0.5%; estimated peaks were in-
cluded in completion of clustering.
HPLC
HPLC protein fractionation was performed using a liquid 
chromatography system (Shimadzu, Columbia, MD). The 
HPLC system included pump, system controller, manual 
injector with a 500-μl injection loop, ultraviolet-visual (UV-
Vis) detector set at 220 nm, and fraction collector (all Shi-
madzu). The HPLC system was controlled with a Dell com-
puter and EZStart chromatographic software (Shimadzu). 
The mobile phase consisted of 0.1 M ammonium acetate, 
pH 4.0, as mobile phase A and 0.1 M ammonium acetate + 
0.5 M NaCl, pH 4.0, as mobile phase B. Chromatographic 
separations were achieved using a weak cation exchange 
column (100 × 2.1 mm; Eprogen, Darien, IL). The flow rate 
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was set at 0.2 ml/min. Before sample injection, the chro-
matographic column was pretreated with 10 mM HCl for 
20 min and equilibrated with mobile phase A. After sample 
injection, mobile phase A was continued for 30 min then 
mobile phase B continued from 30 min to 60 min. A total 
of 400 μg of CHAPS-lysed cells were injected onto the col-
umn (200 μg at 0 and 12 min of mobile phase A). Under 
these chromatographic conditions, bound proteins were 
eluted at 40-50 min. The eluted fractions were dialyzed us-
ing CelluSep® H1 cellulose membranes (Membrane Filtra-
tion Products, Seguin, TX).
In Gel Tryptic Digestion
HPLC fractions were diluted with NuPAGE® LDS buf-
fer (Invitrogen, Carlsbad, CA) and then separated by elec-
trophoresis. In this study, 20 μg of each fraction was ap-
plied to each well of a NuPAGE® Novex 10% Bis-Tris 
(Invitrogen) gel and, after electrophoresis, stained by bril-
liant blue G-colloidal concentrate (Sigma). Specific pro-
tein bands corresponding to molecular weights of interest 
were cut out using a clear razor blade. After destaining 
with 50% ACN, 50 mM NH4HCO3/50% ACN, and 10 mM 
NH4HCO3/50%, the gel slices were dried then incubated 
with trypsin (Promega; Madison, WI) for 12-16 h. All pep-
tides extracted by 0.1% trifluoroacetic acid/60%ACN 
were pooled into a glass tube and dried prior to LC-MC/
MS tests.
Protein Identification by LC-MS/MS
The peptides were resuspended in 0.1% formic acid in 
HPLC-grade water and the ionized peptides were detected 
on a QSTAR LC-MS/MS system (Applied Biosystems, Fos-
ter City, CA). The spectra from LC-MS/MS analysis were 
searched using Mascot search engine from Matrix Science 
(http://www.matrixscience.com/). All protein identifica-
tions were confirmed by three criteria, including (1) detec-
tion of more than two peptides, (2) protein score of >100, 
and (3) protein mass of <17 kDa.
Western Blot Assays
HPLC fractions of three MP were diluted with Nu-
PAGE LDS sample buffer, and 5 μg of each sample was 
applied to each well of a NuPAGE Novex 10% Bis-Tris 
gel (Invitrogen). The gel was transferred to Immobilon-
P PVDF transfer membrane (Millipore, Bedford, MA). 
After blocking with 3% milk in TBS, the membrane was 
incubated with sheep anti-mouse SOD antibodies (Cal-
biochem, San Diego, CA) followed by incubation with 
horseradish peroxidase-conjugated anti-sheep IgG (Cal-
biochem). A chemiluminescent signal was detected us-
ing SuperSignal® West Pico Chemiluminescent substrate 
(Pierce). The density of protein bands was determined 
using the GelExpert software system (Nucleotech, San 
Carlos, CA).
Statistical Analysis
We applied discriminant analysis to the log intensities of 
peaks whose distributions were found to differ by MP sub-
type. Data from the Biomarker Wizard® software 3.2 were 
exported for statistical analysis using SAS® software (SAS 
Institute, Cary, NC). Kruskal-Wallis nonparametric analy-
sis of variance was used to identify peaks for which there 
were statistically significant differences in the distribution 
of intensity scores among the three sample types. Because 
of the large numbers of comparisons made, only those as-
sociated with P-values of <0.0001 were listed as signifi-
cant. Following the recommendations of Yasui et al. (2003), 
we analyzed significant peaks in the mass charge range of 
1,500-20,000 in a stepwise discriminant analysis. We then 
used canonical tests to define a linear construct of peak lo-
cations providing maximum discrimination among the MP 
subtypes. To estimate accuracy, we employed a “leave one 
out” approach by computing canonical variables using all 
but one of the observations. The canonical variables were 
then used to predict the subtype membership of the obser-
vation excluded from the calculations. This process pro-
duces a more unbiased estimate of the misclassification rate 
than that obtained from using the data set in toto.
Results
Protein Profiling of MP Subtypes
We used SELDI-TOF ProteinChip assays to identify po-
tential cytosolic proteins of BM and SPL macrophages and 
MG. SELDI-TOF combines one step fractionation of pro-
teins with mass spectrometry. Figure 1a-e shows five spec-
tra representing protein profiles of cell lysates of SPL mac-
rophages from five independent experiments. Higher 
variability of several peak intensities (e.g., peak 3,977.4 m/
z), as compared with other peaks (e.g., 8,568.5 m/z), were 
observed. Nevertheless, the SELDI-TOF spectra, in general, 
demonstrate reproducible spectral patterns. A total of 91 
spectra were prepared from the cell lysates of BM and SPL 
macrophages and MG after Triton X-100 cell lysis. These 
were combined in one file and analyzed by the Biomarker 
Wizard program for peak detection. Out of 58 peaks, Krus-
kal-Wallis analysis identified 19 proteins for which peak 
intensities differed significantly among MP subtypes (P < 
0.0001). Table 1 presents a list of “potential” protein loca-
tions and median peaks representing proteins. Four peaks 
were observed to be higher in MG than in BM, and the 
other MG peaks had similar or lesser intensity than those 
for BM. Of four peaks with higher intensities, two peaks 
of 7510.2 and 14999.3 m/z showed similar intensities with 
SPL, while the other two, 7410.3 and 14803.6 m/z, showed 
the highest intensity in all three MP subtypes (Fig. 2b,d). 
Three peaks of 3775.6, 3929.7, and 11318.4 m/z were not 
detected in MG but were present in BM and SPL lysates 
(Fig. 2a,c). 
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Figure 1. SELDI-TOF ProteinChip® spectra reproducibility tested with SPL macrophage lysates. a,b: represent spectra of identical cell ly-
sate and ProteinChips®. c: Spectrum of the same cell lysates as (a) and (b), but using a replicate chip. d,e: represent spectra from distinct 
cell lysates and chips. Triton X-100 lysis buffer was used to generate the SPL lysates.
Table 1. SELDI-TOF Analysis of MP Subtypes Using Triton X-100 Lysis Buffer*
                                                                     BM                                           SPL                                             MG
Peak No.a         m/zb                   Mean                   SEM               Mean              SEM                   Mean                  SEM 
 2 3775.6 0.42 0.03 0.60 0.08 0.17 0.02 
 3 3929.7 0.65 0.06 0.79 0.04 0.36 0.02 
 4 3985.1 2.11 0.17 3.06 0.52 1.03 0.09 
 5 4042.6 0.77 0.04 1.23 0.09 0.58 0.04 X
 6 4097.2 0.41 0.03 0.55 0.06 0.23 0.02 
 7 4158.3 0.49 0.03 0.52 0.07 0.19 0.02 
 8 4197.8 0.48 0.03 0.58 0.06 0.25 0.02 
 19 7410.3 1.05 0.05 1.97 0.15 2.67 0.13 
 20 7510.2 0.61 0.03 0.91 0.06 1.03 0.05 X
 23 8456.6 1.03 0.07 2.02 0.16 1.04 0.06 X
 27 10394.4 1.48 0.08 2.59 0.20 1.23 0.09 
 30 11110.0 1.37 0.15 2.92 0.30 1.05 0.10 X
 31 11318.4 1.54 0.34 2.37 0.46 0.54 0.13 
 32 11511.2 0.31 0.05 0.55 0.07 0.12 0.02 
 33 11666.0 1.10 0.08 1.41 0.09 0.38 0.04 
 34 11847.4 0.39 0.03 0.66 0.04 0.25 0.03 X
 39 14803.6 2.47 0.11 5.13 0.35 7.05 0.37 X
 40 14999.3 0.87 0.04 1.63 0.09 1.89 0.08 
 42 15857.1 0.77 0.04 1.02 0.08 0.42 0.03 X
* Kruskal-Wallis analysis of variance comparing distribution of peak intensities across MP subtypes. X = Peaks selected as useful 
for prediction for subset membership.
a A total 58 peaks were detected from data generated from SELDI-TOF ProteinChip® assays and were numbered 1-58.
b Mass/charge (m/z) is indicated as median mass of corresponding peaks from all spectra.
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Detergents Affect Protein Profiling
To examine how detergents affect SELDI-TOF spectra, we 
lysed cells using 2% CHAPS and generated 92 spectra from 
BM and SPL macrophages and MG in identical manner as 
those 91 spectra analyzed following 2% Triton X-100 lysis. 
In this comparison, all spectra from MP lysates prepared 
with CHAPS were combined in one file and analyzed us-
ing Biomarker Wizard generating a total of 62 peaks. Sta-
tistical comparisons based on absolute intensity yielded 18 
significantly different peaks among the MP subtypes (P < 
0.0001). Table 2 presents a summary of peaks, characteristic 
for BM and SPL macrophages and MG. Protein peaks with 
both higher and lower intensities were observed for the 
three MP subtypes (Fig. 3). Spectral comparisons between 
SPL and BM macrophages showed that all 18 peaks were 
higher in SPL macrophages. The results from two experi-
ments yielded similar results. In particular, eight peaks of 
3986.6, 4043.3, 5656.9, 8457.2, 8573.4, 10394.5, 11121.6, and 
15852.8 m/z showed highest intensity in SPL relative to 
other MP subtypes (Fig. 3). The profiles of MG showed four 
higher and two lower peaks, as compared with BM macro-
phages. Four peaks of higher 7412.0, 7729.0, 14807.3, and 
15018.0 m/z were higher in MG than in BM and SPL mac-
rophages (Fig. 3b,c,d). In contrast, two peaks of 3986.6 and 
15852.8 m/z were detected in BM and SPL macrophages, 
but not in MG (Fig. 3a,d). 
Differences in protein profiles were detected regard-
less of the lysis buffer used. However, CHAPS and Triton 
X-100 elicited different protein profiles (Tables 1 and 2). 
Comparison of the data sets between CHAPS- and TritonX-
100-lysed cells showed that seven peaks of 3986.6, 4043.3, 
7412.0, 8457.2, 10394.5, 14807.3, and 15852.8 m/z, summa-
rized in Table 2, were detected in both lysis conditions. 
In contrast, seven peaks of 5191.6, 5656.9, 7729.0, 8573.4, 
11243.0, 12675.4, and 14001.9 m/z were detected only in 
CHAPS-lysed cells and showed significantly higher intensi-
ties in SPL macrophages and/or MG (Fig. 3). In cells lysed 
with Triton X-100, four proteins of 7510.2, 11318.4, 11511.2, 
and 11847.4 m/z showed higher intensities in SPL mac-
rophages, two peaks of 7510.2 and 11318.4 m/z showed 
higher and lower intensities in MG, respectively. However, 
no significant changes in these peaks were found in spectra 
of CHAPS-lysed cells. The results demonstrate that com-
parisons of spectra between cell groups must take into ac-
count how the cell lysates were prepared.
Canonical Analysis of MP Subtypes
We used the log intensities of peak distributions, differing 
by subtype (Tables 1 and 2) in a discriminant analysis to as-
sess cell membership. The peak identified at a median of 
27,303.4 identified in the analysis of the CHAPS data was 
eliminated from this analysis, as it fell outside the ranges 
recommended by Yasui et al. (2003). Thus, 19 and 17 sta-
tistically significant peaks were used in the analysis of the 
Triton X-100 and CHAPS data, respectively. The stepwise 
discriminant analysis identified seven peaks for the Tri-
ton X-100 data and eight peaks in the CHAPS data, which 
were useful in the classification of samples into subtypes. 
Using these peaks, we produced canonical variables with 
the canonical discriminant procedure. The first two canon-
ical variables provided excellent discrimination between 
the MG and the other two macrophage subtypes (Fig. 4a,b). 
The separation of the BM and SPL macrophages was more 
limited. Nevertheless, assigning samples to subtypes, i.e., 
Table 2. SELDI-TOF Analysis of MP Subtypes Using CHAPS Lysis Buffer*
                                                                      BM                                          SPL                                            MG
Peak No.a            m/zb                    Mean                SEM                Mean                 SEM                Mean                 SEM 
 4  3986.6 1.60 0.14 2.18 0.30 0.76 0.09 
 5  4043.3 0.59 0.04 0.91 0.06 0.49 0.05 
 6  4191.3 0.35 0.03 0.49 0.04 0.22 0.03 
 13  5191.6 0.33 0.03 0.59 0.04 0.34 0.04 X
 16  5656.9 0.75 0.11 1.76 0.14 1.10 0.16 
 20  7412.0 0.61 0.04 1.52 0.12 2.00 0.14 
 22  7729.0 0.44 0.03 0.55 0.04 0.89 0.06 
 23  8457.2 0.71 0.05 1.63 0.11 0.80 0.05 
 24  8573.4 1.89 0.18 2.96 0.18 1.49 0.16 X
 26  10394.5 1.30 0.09 2.25 0.16 0.96 0.08 X
 27  11121.6 1.19 0.14 2.23 0.21 0.80 0.08 
 28  11243.0 0.54 0.08 1.25 0.10 0.71 0.12 X
 33  12675.4 0.35 0.04 0.51 0.04 0.20 0.02 
 36  14001.9 0.50 0.08 1.33 0.10 0.87 0.13 
 38  14807.3 1.52 0.11 4.04 0.28 5.21 0.37 
 39  15018.0 0.52 0.03 1.16 0.06 1.37 0.09 X
 42  15852.8 0.58 0.03 0.89 0.06 0.33 0.02 X
 45  27303.4 0.20 0.03 0.24 0.03 0.07 0.01 
* Kruskal-Wallis analysis of variance comparing distribution of peak intensities across MP subtypes. X = Peaks selected as useful 
for prediction of subtype membership.
a A total 61 peaks were detected from data generated using SELDI-TOF ProteinChip® assay and were numbered 1-61.
b Mass/charge (m/z) is indicated as median mass of corresponding peaks from all spectra.
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MG: canonical variable 1 (CV1) value < 0; BM: CV1 > 0; 
CV2 < 0; SPL: CV1 > 0; CV2 > 0, led to the misclassifica-
tion of only three of 91 samples from the Triton X-100 ly-
sates: one BM sample was misclassified as SPL, and two 
SPL samples were misclassified, one as BM and one as MG. 
The “leave one out” estimate of the misclassification rate 
was also 3/91 (3%). Analysis of the CHAPS lysates led to 
the misclassification of four of 92 samples (one SPL as BM, 
three BM as SPL), with the “leave one out” estimate of the 
misclassification rate being 7/92 (8%). 
Protein Identification by LC-MS/MS
To identify the unique proteins determined by SELDI-
TOF analysis, pre-fractionation was required. Here, the de-
sign linked SELDI-TOF and HPLC. The techniques used 
a WCX2 ProteinChip (SELDI-TOF) and WCX column 
(HPLC). A representative chromatogram is shown in Fig-
ure 5a. After sample injections, two peaks were detected at 
4.5 min and at 16.5 min during washing and one peak was 
detected at 42.5 min during elution. The chromatographic 
pattern was reproducible among all three MP subtypes 
(data not shown). We collected the fractions that contained 
the peak detected at 42.5 min during elution. To exam-
ine whether the HPLC fractions showed spectra that cor-
responded to the SELDI-TOF, we performed ProteinChip 
assays from the HPLC fractions of three MP subtypes us-
ing a WCX2 chip. Sixty peaks were detected from the spec-
tra performed from the HPLC fractions of three MP sub-
types (Fig. 5b). Spectral differences among the whole cell 
lysates and HPLC fractions might be due to differences be-
tween protein binding affinities of the WCX2 chip and col-
umn. These results revealed that spectral profiling obtained 
following HPLC fractionation corresponded to SELDI-TOF 
analysis. 
We then separated the proteins enriched by HPLC on 
1D SDS-PAGE and the protein bands at ~17 kDa were col-
lected (Fig. 5c). After in-gel tryptic digestion of the bands, 
the resultant peptides were analyzed by LC-MS/MS; da-
tabase searching revealed 16 proteins obtained after WCX 
protein binding and present in the three MP subtypes (Ta-
ble 3). Five proteins, lysozyme M precursor, AK007994 NID, 
lipid-binding protein, thioredoxin, and ubiquitin, were de-
tected in all three MP subtypes. However, some proteins 
were detected only in one or two of MP subtypes. Next, we 
compared the protein mass identified by LC-MS/MS with 
those of whole cell lysates or HPLC fractions detected by 
SELDI-TOF (Table 3). Five proteins, SOD, lipid-binding 
protein, D-dopachrome tautomerase, AK002403 NID, and 
ubiquitin, were matched less than 1.0% mass accuracy of 
proteins detected in HPLC fractions between SELDI-TOF 
and LC-MS/MS. Three proteins, SOD, lipid-binding pro-
tein, and ubiquitin, were detected both in whole cell lysates 
and HPLC fractions of the MP subtypes. Two proteins, in-
cluding lipid-binding protein and ubiquitin, were identi-
fied in all three MP subtypes, and showed spectral peaks of 
15018.0 and 8573.4 m/z by SELDI-TOF. SOD was matched 
at 0.3% and 0.2% mass accuracy by SELDI-TOF spectra of 
whole cell lysates and by analysis of HPLC fractions. Inter-
estingly, SOD was not detected in HPLC fractions of MG 
by LC-MS/MS, as the protein peaks with 15852.8 m/z was 
lower in MG whole cell lysates than in BM and SPL whole 
cell lysates (Tables 2 and 3). To confirm the protein expres-
sions of SOD in all MP subtypes, Western blot was per-
formed in HPLC fractions of the three MP subtypes. Three 
independent experiments demonstrated that the expression 
of SOD was lowest in MG when compared with BM and 
SPL macrophages (Fig. 6). These results supported the data 
from SELDI-TOF, which MG had a low intensity of peak 
15852.8 m/z on WCX2 chip, and demonstrated the identifi-
cation of 15852.8 m/z protein peak as SOD. 
Discussion
Although residential tissue macrophage, such as Kupffer 
cells, alveolar macrophages, and MG, originate from com-
mon bone marrow progenitors, they display tissue hetero-
Figure 4. Analysis of 183 SELDI-TOF ProteinChip® spectra dem-
onstrating two-dimensional distribution of canonical variables for 
BM macrophages (plus), SPL macrophages (closed circle), and MG 
(opened square). Analyses shown are with Triton X-100 (a) and 
CHAPS (b) lysis buffers.
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Figure 5. Fractionation of BM and SPL macrophages and MG cell lysates by HPLC. a: Chromatograph of HPLC fractionation of MP cell 
lysates injected twice into a WCX column at time points marked with arrows. b: SELDI-TOF ProteinChip® spectra were derived from 
HPLC fractions from BM and SPL macrophages and MG. Spectral peaks marked with red indicate the identical peaks of “putative” pro-
teins shown in Table 2. c: One dimensional (1D) gel of HPLC fractions of BM and SPL macrophages and MG. Protein bands 1-7 were cut 
then collected for protein identification using LC-MS/MS.
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geneity. Differences among macrophage subtypes likely 
result from combinations of programmed cellular differen-
tiation, tissue distribution, and responsiveness to endoge-
nous and exogenous stimuli (Gordon et al., 1988; Ogawa 
1993; Valledor et al., 1998). Thus, if genetically identical, 
when the cells are removed from their normal environment 
and cultivated under identical conditions, they would 
show morphological and functional similarities. We dem-
onstrated that the proteomes of MG, SPL, and BM macro-
phages could be distinguished one compared to the other. 
Indeed, MP show unique proteomic profiles even when 
cultured under identical conditions. These results serve to 
extend prior MP phenotypic heterogeneity studies, includ-
ing M-CSF dependency (Cecchini et al., 1994; Naito et al., 
1996; de Villier et al., 1998).
ProteinChip technology is a new technology used to 
study proteomic profiles in biological samples, such as se-
rum, cerebrospinal fluid, and cell or tissue extracts (Mer-
chant and Weinberger, 2000; Wulfkuhle et al., 2001; Car-
rette et al., 2003; Luo et al., 2003; Carlson et al., 2004), and 
is used in biomarker discovery (Ball et al., 2002; Choe et 
al., 2002; Yasui et al., 2002; Hayman and Przyborski, 2004). 
We used SELDI-TOF to identify protein patterns in BM 
and SPL macrophages and MG, and showed statistical dif-
ferences among three MP subtypes. Protein profiling also 
demonstrated that SPL macrophages showed peak pat-
terns similar to BM macrophages using both lysis extrac-
tion methods. The results were supported by canonical 
analysis. While profiles of SPL macrophages showed sim-
ilar or higher intensity than BM spectra, profiles of MG 
showed similar or lower intensities when compared with 
BM macrophages. Characterization of MG is commonly 
performed by cytofluorometry and immunohistochemis-
try (Giulian and Baker, 1986; Ulvestad et al., 1994; Giulian 
et al., 1995; Becher and Antel, 1996). The phenotype of MG 
in the normal CNS is described as being in an inactive state 
(Perry and Gordon, 1991; Sedgwick et al., 1991). However, 
because activation of MG promotes immune responses, the 
balance of protective and destructive action is directly re-
lated to environmental cues acquired during neurode-
generative disorders (Allan and Rothwell, 2001; Nguyen, 
2002). The MG proteome operative during neurodegener-
ative disorders may be studied if the cells “unique” prop-
erties can be maintained during cultivation. Trying to tease 
out unique signatures of MG is fraught with other difficul-
ties. Indeed, it is likely that MG originate from BM progen-
Table 3. Protein Identification for MP Subtypes*
                                                                                                                                            Sequence coverage (%)                           SELDI-TOFa
                                                                                                                                                                                                  Whole cell                HPLC
Accession no. Protein name                                  Mass         BM       SPL                MG                lysate                   fraction
A31239 Lysozyme (EC 3.2.1.17) M precursor: mouse 16678 29 22 25  
GLMB_MOUSE Glia maturation factor beta (GMFβ):  16581 ND 7 ND  
    Mus musculus (mouse) 
BAB25396 AK007994 NID: Mus musculus 15934 41 39 16  
SODC_MOUSE Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)  15802 23 23 ND 15852.8 (0.3) 15830.2 (0.2) 
    Mus musculus (mouse) 
Q9R1A1 Sodium-hydrogen exchanger regulatory 15367 22 22 ND 
  factor (fragment): Mus musculus (mouse)  
A47497 Lipid-binding protein, kcratinocyte: mouse 15127 14 23 22 15018.0 (0.7) 14979.0 (1.0)
DOPD_MOUSE D-dopachrome tautomerase (EC 5.3.3.-):  12938 ND 37 ND  13062.4 (1.0) 
    Mus musculus (mouse)
BAC33989 AK049929 NID: Mus musculus 12803 35 ND 20 12675.4 (1.0) 
BAB28442 AK012742 NID: Mus musculus 12422 19 19 ND  
CCMS Cytochrome c [validated]: mouse 11598 ND 38 26  
THIO_MOUSE Thioredoxin (ATL-derived factor) 11537 36 38 21   
     (ADF): Mus musculus (mouse)
Q7TQ15 Dosage compensation-related protein  11176 36 36 ND 11121.6 (0.5)  
    DPY30: Mus musculus (mouse) 
BAB22074 AK002403 NID: Mus musculus 11039 29 ND ND  11082.1 (0.4)
Q9J195 CPN10-like protein: Mus musculus (mouse) 10971 ND 23 ND  
JC4760 SMT3 protein: human 10864 23 23 ND  
UQBO Ubiquitin: bovine (tentative sequence) 8560 80 64 64 8573.4 (0.2) 8650.7 (1.0)
* Protein identification was performed by LC-MS/MS using HPLC fractions of three MP cell lysates.
a Average of protein mass in whole cell lysates and HPLC fractions are shown. Protein mass accuracy between SELDI-TOF and database is indicated 
as percentage in parentheses.
MP, mononuclear phagocytes; BM, bone marrow; SPL, spleen; MG, (brain) microglia; ND, not detected.
Pr o tE o mi c f i n gE r P r i n ts d i s ti n g ui s h mi c r o g li a an d mac r o P h a g E P o P ul ati o n s   171
itors and migrate to brain during fetal development. The 
same BM progenitors also give rise to spleen and other tis-
sue macrophages. Moreover, embryonic and adult mouse 
brain may themselves contain progenitor cells (Alliot et 
al., 1991; Richardson et al., 1993). MG may also turn over 
at a significantly slower rate than other tissue macrophage 
(Kennedy and Abkowitz, 1997). Thus, distinctive features 
of MG may be principal in development, differentiation, 
and plasticity.
While protein analysis have been established as new 
tools for understanding various biological problems, dif-
ferent mass spectrometric techniques for identification 
and posttranslational modifications have been established 
as well as isolation and separation methods for analysis 
of highly complex samples by classical separation tech-
niques, such as two-dimensional gel electrophoresis and 
liquid chromatography (Lescuyer et al., 2004; Reinders et 
al., 2004). Recently, these techniques have been helpful for 
macrophage proteome analysis (Walsh et al., 1995; Yeung 
and Stanley, 2003; Yu et al., 2003; Verhoeckx et al., 2004; 
Dupont et al., 2004). In the present study, we used HPLC as 
a protein separation method and LC-MS/MS as an identifi-
cation tool. These analyses showed that of 16 possible pro-
teins three were identified as SOD, lipid-binding protein, 
and ubiquitin. These corresponded to the spectral peaks de-
tected by SELDI-TOF. The protein peak detected at 15852.8 
m/z in MG cell lysates showed lower intensities than those 
in BM and SPL macrophages on the WCX2 chip. This pro-
tein peak was identified as SOD in the HPLC fraction of all 
MP subtypes but showed the lowest level of expression in 
MG. The results, most significantly, showed that SELDI-
TOF and HPLC can be linked through the use of a WCX 
chip and column.
Interestingly, the lowest levels of SOD were found in 
MG. SOD regulates cellular oxygen metabolism and free 
radical formation. Oxygen free radicals are linked to the 
pathogenesis of a number of neurodegenerative disorders, 
including amyotrophic lateral sclerosis and human immu-
nodeficiency virus (HIV) dementia, and are associated with 
inflammatory responses (Pasinelli et al., 1998; Boven et al., 
1999; Marikovsky et al., 2003; Nguyen et al., 2004). Macro-
phages secrete SOD de novo, but it is increased following 
cell activation by lipopolysaccharide and tumor necrosis 
factor- (TNF-) (Marikovsky et al., 2003). In our study, the 
protein levels in HPLC fraction were different between MG 
and the other MP subtypes. The difference of quantitative 
expression might result from the difference of the binding 
affinity of SOD obtained from each MP against WCX sur-
face. Although it remains unknown whether SOD qualita-
tively or functionally differ among the three MP, these re-
sults might lead to new insights into their roles in health 
and disease.
Macrophages play a role in tissue homeostasis as spe-
cialized phagocytic cells able to produce trophic, cytotoxic, 
and regulatory molecules that mediate inflammation and 
repair, following pathogen invasion and cellular damage 
(Gordon, 2003). The immunological changes in residential 
cells have influences on tissue structure and function dur-
ing disease progressions. Therefore, it is important to fur-
ther characterize the protein expression profiles in resting 
and activated macrophages, as a first step towards under-
standing how proteins affect a unique MP subtype.
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Figure 6. Immunoblot detection of SOD 
in HPLC fractions of BM and SPL mac-
rophages and MG. Western blot anal-
ysis of protein bands of SOD (15,802 
Da) marked with an arrow. A repre-
sentative illustration of one of three in-
dependent experiments is shown. The 
relative densities of protein bands for 
the immunoblot shown is included.
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